HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis
Open accessThe DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Abstract
Cell death is a key driver of disease progression and carcinogenesis in chronic liver disease (CLD), highlighted by the well-established clinical correlation between hepatocellular death and risk for the development of cirrhosis and hepatocellular carcinoma (HCC). Moreover, hepatocellular death is sufficient to trigger fibrosis and HCC in mice. However, the pathways through which cell death drives CLD progression remain elusive. Here, we tested the hypothesis that high-mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) with key roles in acute liver injury, may link cell death to injury responses and hepatocarcinogenesis in CLD. While liver-specific HMGB1 deficiency did not significantly affect chronic injury responses such as fibrosis, regeneration, and inflammation, it inhibited ductular/progenitor cell expansion and hepatocyte metaplasia. HMGB1 promoted ductular expansion independently of active secretion in a nonautonomous fashion, consistent with its role as a DAMP. Liver-specific HMGB1 deficiency reduced HCC development in 3 mouse models of chronic injury but not in a model lacking chronic liver injury. As with CLD, HMGB1 ablation reduced the expression of progenitor and oncofetal markers, a key determinant of HCC aggressiveness, in tumors. In summary, HMGB1 links hepatocyte death to ductular reaction, progenitor signature, and hepatocarcinogenesis in CLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M. E., Al-Abed, Y., Andersson, U., Tracey, K. J., & Antoine, D. J. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00389 · Cited by 407 · cited 1×
“(80) for the indicated durations (Figure 5, B–F and H; Supplemental Fig-”
BackgroundSelf-citationRetractedAntoine, D. J., Jenkins, R. E., Dear, J. W., Williams, D. P., McGill, M. R., Sharpe, M. R., Craig, D. G., Simpson, K. J., Jaeschke, H., & Park, B. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.019 · Cited by 309
Self-citationRetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
A scaling normalization method for differential expression analysis of RNA-seq data
Robinson, M. D., & Oshlack, A. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r25 · Cited by 7,876 · cited 1×
“with the trimmed mean of M values method (TMM) (79).”
MethodMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Templeton, A. J., McNamara, M. G., Šeruga, B., Vera-Badillo, F. E., Aneja, P., Ocaña, A., Leibowitz-Amit, R., Sonpavde, G., Knox, J. J., Tran, B., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju124 · Cited by 2,829 · cited 1×
“8D), a cell population that contributes role to the development of liver cancer (60), and whose numbers positively correlate with worse prognosis (61, 62), in HCC.”
BackgroundLong-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M. M. A., Ellis, E., van Wenum, M., Fuchs, S. A., de Ligt, J., et al. (2015) · Cell · doi:10.1016/j.cell.2014.11.050 · Cited by 1,619
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346 · cited 2×
“the size of the largest tumor with a caliper, respectively (57).”
BackgroundSelf-citation
Cited by
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Self-citationApoptosis and necroptosis in the liver: a matter of life and death
Schwabe, R. F., & Luedde, T. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0065-y · Cited by 582
Self-citationInflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yang, Y., Kim, S., & Seki, E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676806 · Cited by 449
The multifunctional protein HMGB1: 50 years of discovery
Tang, D., Kang, R., Zeh, H. J., & Lotze, M. T. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00894-6 · Cited by 371
“HMGB1 overexpression is commonly observed in multiple forms of cancer and has oncogenic effects, by enhancing anti-apoptotic mechanisms, inflammation, immune system evasion and aerobic glycolysis 117,118 .”
BackgroundMetal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 209
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 205
Zhan, X., Wu, R., Kong, X., You, Y., He, K., Sun, X., Huang, Y., Chen, W., & Duan, L. (2023) · Cancer Communications · doi:10.1002/cac2.12388 · Cited by 176
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy
Wu, R., Fan, X., Wang, Y., Shen, M., Zheng, Y., Zhao, S., & Yang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833878 · Cited by 117
“Moreover, liver immune regulation was also associated with damage-associated molecular patterns (DAMPs) such as high mobility group protein 1(HMGB1) and IL33 (90, 91), NOD-like receptor family, pyrin domain containing 3(NLRP3) (92), TLRs (TLR3, TLR4, TLR7, TLR9) (93) and complements (94).”
BackgroundHMGB1 protein as a novel target for cancer
Tripathi, A. S., Shrinet, K., & Kumar, A. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.03.002 · Cited by 126
High‐Mobility Group Box‐1 and Liver Disease
Gaskell, H., Ge, X., & Nieto, N. (2018) · Hepatology Communications · doi:10.1002/hep4.1223 · Cited by 106
“(12‒14) In this latter role, HMGB1 acts as a proinflammatory cytokine that contributes to multiple injuries, including those from the liver, such as warm and cold ischemia/reperfusion (I/R) injury,(15‒27) sepsis,(23,28‒32) acetaminophen (APAP) intoxication,(23,33‒40) alcoholic liver disease (ALD),(41‒43) fibrosis,(44‒…”
BackgroundInfluentialMederacke, I., Filliol, A., Affo, S., Nair, A., Hernandez, C., Sun, Q., Hamberger, F., Brundu, F., Chen, Y., Ravichandra, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abe5795 · Cited by 103
Self-citation(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“Ultimately, chronic hepatocyte injury and cell death lead to the release of DAMPs that trigger liver in fl ammation or carcinogenic pathways in the liver [78].”
Self-citationLin, Q., Wu, Z., Yue, X., Yu, X., Wang, Z., Song, X., Xu, L., He, Y., Ge, Y., Tan, S., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102676 · Cited by 81
“Liver CSCs not only express progenitor markers such as EPCAM and CD133 [6,7] but also oncofetal genes such as alpha-fetoprotein (AFP) and H19 [13], all of which are associated with HCC development and clinical outcomes [14].”
BackgroundHMGB1 in the interplay between autophagy and apoptosis in cancer
Chen, R., Zou, J., Zhong, X. Y., Li, J., Kang, R., & Tang, D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216494 · Cited by 87
Role of High-Mobility Group Box-1 in Liver Pathogenesis
Khambu, B., Yan, S., Huda, N., & Yin, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215314 · Cited by 79
“Hepatocyte-specific HMGB1-deleted mice, when subjected to two-third partial hepatectomy or single injection of CCl4, did not show any effect in the regulation of hepatocyte proliferation in either model [43].”
BackgroundInfluentialHoste, E., Maueröder, C., Hove, L. V., Catrysse, L., Vikkula, H., Sze, M., Maes, B., Karjosukarso, D. W., Martens, L., Gonçalves, A. C., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.104 · Cited by 78
“Neutrophils represent the main cell type involved in the early immune response during injury repair, where they can produce NETs that have recently been implicated in various infectious and inflammatory pathologies, including sepsis, liver injury, atherosclerosis, and asthma (Hernandez et al., 2018; Papayannopoulos, 2…”
BackgroundSelf-citationThe role of transketolase in human cancer progression and therapy
Hao, S., Meng, Q., Sun, H., Li, Y., Li, Y., Gu, L., Liu, B., Zhang, Y., Zhou, H., Xu, Z., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113607 · Cited by 70
Peng, H. Y., Yang, M., Feng, K., Lv, Q., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01887-0 · Cited by 77
Li, M., Lu, Y., Li, Y., Tong, L., Gu, X., Meng, J., Zhu, Y., Wu, L., Feng, M., Tian, N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3776 · Cited by 74
High Mobility Group Box 1 in Human Cancer
Rapoport, B. L., Steel, H. C., Theron, A. J., Heyman, L., Smit, T., Ramdas, Y., & Anderson, R. (2020) · Cells · doi:10.3390/cells9071664 · Cited by 74
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
García‐Pras, E., Fernández‐Iglesias, A., Gracia‐Sancho, J., & Pérez‐del‐Pulgar, S. (2021) · Cancers · doi:10.3390/cancers14010048 · Cited by 66
“Recent data from mouse models have shown that HMGB1 activates ductular reactions via cell-extrinsic mechanisms and RAGE receptor, and promotes hepatocyte transformation [36].”
BackgroundYue, P., Zhang, Y., Liu, L., Zhou, K., Xia, S., Peng, M., Yan, H., Tang, X., Chen, Z., Zhang, D., et al. (2022) · Theranostics · doi:10.7150/thno.74563 · Cited by 65
“To validate the activation of YAP signaling, we applied an antibody that selectively recognized non-phosphorylated, activated YAP1 proteins (aYAP1) [32] to perform immunofluorescence and western blot analysis on sham- and AAC-treated ventricle tissues.”
MethodGarcía‐Jaramillo, M., Spooner, M. H., Löhr, C. V., Wong, C. P., Zhang, W., & Jump, D. Β. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214387 · Cited by 66
Aikawa, S., Deng, W., Liang, X., Yuan, J., Bartos, A., Sun, X., & Dey, S. K. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0429-z · Cited by 59
AGER1 downregulation associates with fibrosis in nonalcoholic steatohepatitis and type 2 diabetes
Dehnad, A., Fan, W., Jiang, J. X., Fish, S. R., Li, Y., Das, S., Mozes, G., Wong, K. A., Olson, K. A., Charville, G. W., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133051 · Cited by 52
“Furthermore, RAGE was required for expansion of RDCs and tumor promotion in an autophagy-deficient model of HCC (36), and HMGB1, another ligand of RAGE, was involved in progenitor responses and hepatocarcinogenesis (37).”
BackgroundHigh Mobility Group Box 1 (HMGB1): Molecular Signaling and Potential Therapeutic Strategies
Datta, S., Rahman, M. A., Koka, S., & Boini, K. M. (2024) · Cells · doi:10.3390/cells13231946 · Cited by 59
Hyun, J., McMahon, R. S., Lang, A. L., Edwards, J. S., Badilla, A. D., Greene, M. E., Stone, G. W., Pallikkuth, S., Stevenson, M., Dykxhoorn, D. M., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007883 · Cited by 48
Yang, G., Xu, Q., Wan, Y., Zhang, L., Wang, L., & Meng, F. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110065 · Cited by 49
Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
Brenig, R. G., Pop, O. T., Triantafyllou, E., Geng, A., Singanayagam, A., Perez‐Shibayama, C., Bešše, L., Cupovic, J., Künzler‐Heule, P., Boldanova, T., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900465 · Cited by 45
microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4
Li, Z., Zhou, Y., Zhang, L., Jia, K., Wang, S., Wang, M., Li, N., Yu, Y., Cao, X., & Hou, J. (2020) · Oncogenesis · doi:10.1038/s41389-020-00282-y · Cited by 45
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis
Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., Dong, Y., Wang, M., Li, Y., Lu, S., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01381-6 · Cited by 45
“5 ml/kg body weight, dissolved in olive oil at a ratio of 1:3) starting from four weeks post the initial DEN injection and lasting for 15 weeks, and were sacrificed eight weeks after the last CCl4 injection as described [20, 21].”
MethodZhao, Z., Hu, Z., Zeng, R., & Yao, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118203 · Cited by 46
Pattern Recognition Receptors: Significance of Expression in the Liver
Zeromski, J., Kierepa, A., Brzezicha, B., Kowala-Piaskowska, A. E., & Mozer‐Lisewska, I. (2020) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00595-1 · Cited by 41
The regulatory mechanism of neutrophil extracellular traps in cancer biological behavior
Wang, H., Zhang, Y., Wang, Q., Wei, X., Wang, H., & Gu, K. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00708-z · Cited by 42
“HMGB1, a damage-associated molecular pattern, has been shown to participate in the growth and progression of cancer [93, 94].”
BackgroundRole of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma
Chen, X., Chi, H., Zhao, X., Pan, R., Wei, Y., & Han, Y. (2022) · Journal of Oncology · doi:10.1155/2022/2521025 · Cited by 45
“HMGB1 plays a vital role in the neutrophil recruitment of acute liver injury in HCC [117].”
BackgroundHe, M., Chu, T., Wang, Z., Feng, Y., Shi, R., He, M., Feng, S., Lin, L., Cai, C., Fang, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147379 · Cited by 45
Immune Cell Migration to Cancer
Ryan, A. T., Kim, M., & Lim, K. (2024) · Cells · doi:10.3390/cells13100844 · Cited by 38
Fang, P., Liang, J., Jiang, X., Fang, X., Wu, M., Wei, X., Yang, W., Hou, W., & Zhang, Q. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00608 · Cited by 37
Tan, Z., Chiu, M. S., Yang, X., Yue, M., Cheung, T. T., Zhou, D., Wang, Y., Chan, A. W. H., Yan, C. W., Kwan, K. Y., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327133 · Cited by 37
Muzumbukilwa, T. W., Nlooto, M., & Owira, P. M. O. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.03.050 · Cited by 36
Hepatic stellate cell heterogeneity: Functional aspects and therapeutic implications
Geng, Y., & Schwabe, R. F. (2025) · Hepatology · doi:10.1097/hep.0000000000001386 · Cited by 41
Self-citationRegulation of HMGB1 release protects chemoradiotherapy-associated mucositis
Im, K.-I., Nam, Y.-S., Kim, N., Song, Y., Lee, E., Lim, J.-Y., Jeon, Y., & Cho, S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0132-x · Cited by 34
Katsumi, T., Guicciardi, M. E., Azad, A. I., Bronk, S. F., Krishnan, A., & Gores, G. J. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00250.2019 · Cited by 34
Programmed Cell Death in Liver Fibrosis
Gao, R., Tang, H., & Mao, J. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s427868 · Cited by 35
“Specifically, High mobility group-1 (HMGB1), a DAMP, is positively correlated with pyroptosis and is released from macrophages and dying cells, thereby exacerbating liver injury.(41,42) Furthermore, dying hepatocytes induced by pyroptosis can release HMGB1, which promotes HSC activation.”
BackgroundGuzmán‐Ruiz, R., Tercero‐Alcázar, C., López‐Alcalá, J., Sánchez-Ceinos, J., Malagón, M. M., & Gordon, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111417 · Cited by 32
Cui, D., Wang, Z., Dang, Q., Wang, J., Qin, J., Song, J., Zhai, X., Zhou, Y., Zhao, L., Lü, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42461-6 · Cited by 32
Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma
Allard, B., Jacoberger-Foissac, C., Cousineau, I., Barèche, Y., Buisseret, L., Chrobák, P., Allard, D., Pommey, S., Ah-Pine, F., Duquenne, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101188 · Cited by 35
Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer
Nakagawa, H., Hayata, Y., Yamada, T., Kawamura, S., Suzuki, N., & Koike, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061745 · Cited by 28
“Very recently, the other alarmin high-mobility group B1 (HMGB1) has been reported to play a key role in chronic liver injury-induced ductular/progenitor cell expansion in the liver (so-called ductular reaction) [81,82].”
BackgroundHomeostatic Role of Autophagy in Hepatocytes
Khambu, B., Yan, S., Huda, N., Liu, G., & Yin, X. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1669939 · Cited by 29
Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)
Shao, L., Li, Z., Wang, M., Ning, Y., Chen, F.-Q., Gao, X.-Q., Yang, C.-T., Wang, H., & Liu, X. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5272 · Cited by 26
“HMGB1 has been found to be involved in a variety of malignancies, including liver cancer (37,51,52), breast cancer (50,53), multiple myeloma (MM) (25), thyroid cance (38), rectal cancer (54), cutaneous melanoma (55), lung cancer (56), gastric cancer (57) and leukemia (58).”
Jung, J., Suh, C., & Kim, H. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1615449 · Cited by 24
Zhu, W., Li, J., Zhang, Y., Zhu, Z., Liu, H., Lin, Y., Hu, A., Zhou, J., Ren, H., & Shi, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.599124 · Cited by 22
“Mounting evidence revealed that HMGB1 was an important tumor-promoting effector in HCC and targeting HMGB1 could significantly restrain HCC progression (29, 30).”
BackgroundThe HMGB1-RAGE axis modulates the growth of autophagy-deficient hepatic tumors
Khambu, B., Hong, H., Liu, S., Liu, G., Chen, X., Dong, Z., Wan, J., & Yin, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2536-7 · Cited by 26
Cancer-associated fibroblasts in carcinogenesis
Zhou, S., Zhao, Z., Wang, Z., Xu, H., Li, Y., Xu, K., Li, W., & Yang, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06071-8 · Cited by 28
“However, this process also generates stress signals that cause unnecessary tissue damage and inflammatory responses in patients with tumors as well as in those who presents precancerous lesions [36].”
Wu, J., Tan, H., Chan, Y.-T., Lu, Y., Feng, Z., Yuan, H., Zhang, C., Feng, Y., & Wang, N. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02967-3 · Cited by 24
“Specifically, liver progenitor cells, the cellular source of carcinogenesis, undergo a series of molecular events caused by chronic liver diseases, including but not limited to sustained DNA damage and increased chromosomal instability [12, 13].”
BackgroundImmune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis?
Li, X., Zhang, Q., Wang, Z., Zhuang, Q., & Zhao, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.802251 · Cited by 24
“In NASH mice, the significant upregulation of HIF-1α in hepatocytes increased proportion of M2 macrophages and promoted liver fibrosis and HCC (Ambade et al., 2016).”
BackgroundInfluentialShang, Y., Yang, H., Li, X., Zhang, Y., Chen, N., Jiang, X., Zhang, Z., Zuo, R., Wang, H., Lan, X., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15858 · Cited by 20
“High-mobility group box 1 protein (HMGB1, or amphoterin) is a damage-associated molecular pattern (DAMP) candidate with key roles in sterile inflammation following neutrophilmediated injury (Hernandez et al., 2018; Huebener et al., 2015).”
BackgroundInfluentialSu, T., Qin, X., Dohmae, N., Wei, F., Furutani, Y., Kojima, S., & Yu, W. (2021) · Metabolites · doi:10.3390/metabo11030167 · Cited by 19
“These data suggested that the increased ganglioside synthesis in DDC-induced liver injury was related to the progenitor response, which is critical for liver tumorigenesis [28].”
BackgroundPerfluorooctane sulfonate aggravates CCl4 ‐induced hepatic fibrosis via HMGB1 / TLR4 /Smad signaling
Wan, C., Gu, T., Ling, J., Qin, Y., Luo, J., Sun, L., Hua, L., Zhao, J., & Jiang, S. (2022) · Environmental Toxicology · doi:10.1002/tox.23458 · Cited by 17
“Recent studies have shown that HMGB1, as an important danger-related molecular pattern, plays an important role in driving inflammatory responses following liver injury.(46,47) Considering the”
BackgroundExtracellular Vesicles: Potential Mediators of Psychosocial Stress Contribution to Osteoporosis?
He, Y., Wuertz‐Kozak, K., Kuehl, L. K., & Wippert, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115846 · Cited by 20
He, Y., Wang, F., Yao, N., Wu, Y., Zhao, Y., & Tian, Z. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02095-2 · Cited by 16
“HMGB1 was originally discovered as a nuclear binding protein, and it has been implicated in various hepatic diseases [9, 23, 24].”
BackgroundAuthorship Issues When Articles are Retracted Due to Research Misconduct and Then Resubmitted
Banerjee, T., Partin, K. M., & Resnik, D. B. (2022) · Science and Engineering Ethics · doi:10.1007/s11948-022-00386-1 · Cited by 16
Fate and functional roles of Prominin 1+ cells in liver injury and cancer
Wu, R. P., Pan, S. Q., Chen, Y., Nakano, Y., Li, M., Balog, S., & Tsukamoto, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-76458-8 · Cited by 16
Pirnie, R., Gillespie, K. P., Weng, L., Mesaros, C., & Blair, I. A. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00161 · Cited by 16
Emerging Players in Autophagy Deficiency-Induced Liver Injury and Tumorigenesis
Yang, H., Ni, H., & Ding, W. (2019) · Gene Expression · doi:10.3727/105221619x15486875608177 · Cited by 14
Macrophage‐derived HMGB1 is dispensable for tissue fibrogenesis
Personnaz, J., Piccolo, E. B., Branchereau, M., Filliol, A. A., Paccoud, R., Moreau, E., Calise, D., Riant, É., Gourdy, P., Heymes, C., et al. (2019) · FASEB BioAdvances · doi:10.1096/fba.2018-00035 · Cited by 15
Self-citationZhao, T., Zhu, Y., Yao, L., Liu, L., & Li, N. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100560 · Cited by 16
Zhang, W., Shao, T., Wang, C., Wang, S., & An, L. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2613502 · Cited by 15
“Dead hepatocytes release DAMPs, which activate KCs and HSCs via Toll-like receptors (TLRs) [80].”
Jin, H., Jiang, Y., Lv, W., Chen, L., Zheng, Y., & Lin, Y. (2021) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2021.101706 · Cited by 12
The dynamics of cell death patterns and regeneration during acute liver injury in mice
Shao, S., Zhang, Y., Li, G., Yu, Z., Cao, Y., Zheng, L., Zhang, K., Han, X., Shi, Z., Cui, H., et al. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13383 · Cited by 11
Reappraisal of Oxidized HMGB1 As a Mediator and Biomarker
Pirnie, R., Gillespie, K. P., Mesaros, C., & Blair, I. A. (2022) · Future Science OA · doi:10.2144/fsoa-2022-0052 · Cited by 12
Khambu, B., Cai, G., Liu, G., Bailey, N. T., Mercer, A., Baral, K., Ma, M., Chen, X., Li, Y., & Yin, X. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01495-x · Cited by 12
“HMGB1 release and pathological effects of extracellular HMGB1 have also been demonstrated in many other types of liver diseases including alcoholic and non-alcoholic fatty liver diseases, liver injury caused by 3,5-diethoxycarbonyl-1,4dihydrocollidine(DDC) diet or Choline-deficient, Ethioninesupplemented (CDE) diet, a…”
BackgroundGarufi, A., D’Orazi, V., Pistritto, G., Cirone, M., & D’Orazi, G. (2023) · Cancers · doi:10.3390/cancers15102678 · Cited by 9
“It has been shown in vivo that HMGB1 promotes disease progression of human HCC [68].”
BackgroundCao, S., Miao, J., Qian, M., Zhu, C. H., Ding, S., Yin, J., Zhu, L., & Zhang, Q. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.789752 · Cited by 9
Transcription factor E4F1 as a regulator of cell life and disease progression
Sun, S., Zhong, B., Zeng, X. Y., Li, J., & Chen, Q. (2023) · Science Advances · doi:10.1126/sciadv.adh1991 · Cited by 11
Emerging Roles of High-mobility Group Box-1 in Liver Disease
Wang, L., Dong, Z., Zhang, Y., & Peng, L. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00317 · Cited by 8
Deng, J., Qin, L., Qin, S., Wu, R., Huang, G., Fang, Y., Huang, L., & Zhou, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s448723 · Cited by 9
“49 Pyroptosis-related proteins and pro-inflammatory factors are secreted in the process of pyroptosis, which can induce an inflammatory response and aggravate liver injury.”
BackgroundFoelsch, K., Pelczar, P., Zierz, E., Kondratowicz, S., Qi, M., Mueller, C., Alawi, M., Hübener, S., Clauditz, T. S., Gagliani, N., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae017 · Cited by 8
Self-citationZhang, Y., Bao, S., Zeng, J., Liu, J., Li, X., Zhang, B., Wang, H., Cheng, Y., Zhang, H., Xia, W. T., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111607 · Cited by 9
HMGB1-Mediated Cell Death—A Crucial Element in Post-Hepatectomy Liver Failure
Brunnthaler, L., Hammond, T. G., Pereyra, D., Santol, J., Probst, J., Laferl, V., Resch, U., Aiad, M., Jankoschek, A. S., Gruenberger, T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137150 · Cited by 9
“In our study as well as in previous reports no correlation between HMGB1 and neutrophil recruitment could be observed [11] arguing against reduced HMGB1-mediated repair processes in this disease context.”
BackgroundAthavale, D., Song, Z., Désert, R., Han, H., Das, S., Ge, X., Komakula, S. S. B., Chen, W., Gao, S., Lantvit, D. D., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1943 · Cited by 8
“[13] In contrast, Hmgb1∆Hep mice treated with DEN and carbon tetrachloride show no difference in YAP protein or its target genes but have reduced hepatocarcinogenesis compared to controls.[14] In this study, we hypothesized that HMGB1 accelerates HCC by activating YAP in Hippo signaling- deficient mice.”
BackgroundA patent review on HMGB1 inhibitors for the treatment of liver diseases
Raj, R., Shen, P., Yu, B., & Zhang, J. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2338105 · Cited by 8
“Another in-vivo analysis of hepatotoxins, such as diethyl-nitrosamine (DEN), thioacetamide (TAA), and CCl 4 -induced HCC models, revealed that HMGB1 secretion was high in instances of fibrosis and cellular injury [27–29].”
BackgroundYan, Y., Ye, X., Chunqing, H., Wu, J., Liu, Y., Zheng, P., Shen, C., Bai, Z., & Tingming, S. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae077 · Cited by 8
Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies
Yu, S., Qian, L., & Ma, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17454 · Cited by 6
Volmari, A., Foelsch, K., Zierz, E., Yan, I., Qi, M., Bartels, K., Kondratowicz, S., Böttcher, M., Reimers, D., Nishibori, M., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1777 · Cited by 6
Self-citationBile ductular reactions in the liver: similarities are only skin deep
Alison, M. R., & Lin, W. (2019) · The Journal of Pathology · doi:10.1002/path.5265 · Cited by 4
“cell death to DR activation [12], while the expression of genes regulated by the transcription factor KLF5 (Krüppel-like transcription factor 5) control interactions between BECs and the ECM, crucial for DR propagation [13].”
BackgroundNatural products as therapeutic interventions for inflammation-mediated cancer
Roy, S., Shaw, R., Pandey, A., & Trigun, S. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-03004-1 · Cited by 4
“Notable examples of DAMPs include interleukin-1 alpha (IL-1α), ATP, and high mobility group box 1 (HMGB1) [28].”
Xiong, B., Li, C., Hong, G., Li, J., Luo, Q., Gong, J., & Lai, X. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05996-9 · Cited by 3
“* p < 0.05 space as damage-associated pattern molecules (DAMPs), which bind to receptors and participate in inflammatory responses, cell differentiation, angiogenesis, tumor metas - tasis, and drug resistance(Hernandez et al. 2018 ; Jube et al. 2012 ).”
BackgroundInfluentialGalmiche, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_13 · Cited by 4
The effect of HMGB1 and RAGE on the clinicopathological and prognostic features of prostate cancer
Lv, D. (2021) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.34 · Cited by 3
Lin, C.-H., Cheng, C., Chiou, Y., Wang, I., & Kuo, C. (2024) · Intervirology · doi:10.1159/000542355 · Cited by 2
Wang, J., Tang, Q., Yuan, Z., Zhang, H., Miao, Y., Shen, W., Shen, W., Yu, Q., Zhang, L., & Jiang, Z. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111752 · Cited by 3
Jiraviriyakul, A., Nensat, C., Promchai, S., Chaiaun, Y., Hoiraya, Y., Yamnak, N., Khutanthong, S., Singpan, N., & Songjang, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083491 · Cited by 2
“Especially in HCC, HMGB1 has been found to be associated with chronic liver injury and hepatocar-cinogenesis [16].”
Correlation of HMGB1, PON-1, MCP-1, and Periodontal P. gingivalis with Amniotic Fluid Fecal Dye
Jin, Z.-A., Li, Y., Chen, W., Wang, Y., Zhao, Y.-K., Sun, X., He, J., Jie, G., & Sun, Y. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/3143102 · Cited by 3
Toll‐like Receptors in Liver Disease
Kim, S. Y., & Seki, E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch57 · Cited by 3
Shen, S., Qiu, X., Yang, G., Peng, Y., Yang, H., Li, J., Qin, J., Tang, H., Liang, H., Zhang, W., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013441 · Cited by 1
“…clinical studies evaluating the impact of C.sinensis infection on long-term survival outcomes following curative resection for HCC are scarce, particularly in regions like Guangxi where C.sinensis and HBV infections are co-endemic, limiting a comprehensive understanding of its prognostic role [15].”
InfluentialIschemic preconditioning promotes hepatic differentiation in human liver organoids
Cimino, M., Tinnirello, R., Orlando, A., Messina, S., Gruttadauria, S., Pagano, D., Conaldi, P. G., Mattina, A., Perriera, R., Zito, G., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1862631 · Cited by 1
“HMGB1 has been increasingly implicated in liver progenitor cell-associated regenerative responses, and transient HMGB1 signaling may promote ductular activation, progenitor plasticity, and differentiation competence through RAGE-and TLR4-dependent pathways (Hernandez et al., 2018).”
Metadata
- Authors
- Hernandez, C., Huebener, P., Pradere, J.-P., Antoine, D. J., Friedman, R. A., & Schwabe, R. F.
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Centre for Inflammation Research (GB)
- Herbert Irving Comprehensive Cancer Center (US)
- Columbia University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2018-05-07
- Volume
- 128
- Issue
- 6
- Pages
- 2436-2451
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5983315
- OpenAlex
- W2790482497
- Cited by
- 110
- References
- 85
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 22 · 2021: 13 · 2020: 15 · 2019: 19 · 2018: 5
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (U01AA021912)
- National Cancer Institute (R01CA200597, P30CA013696)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116620)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- HMGB1, chronic liver disease, hepatocellular carcinoma, hepatocarcinogenesis, hepatocyte death, damage-associated molecular patterns, ductular reaction, liver progenitor cells, liver fibrosis, liver regeneration, liver inflammation
- MeSH terms
- Animals, Child, Preschool, Chronic Disease, Female, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Neoplasms, Male, Neoplasm Proteins, Neoplastic Stem Cells, Hepatocytes, HMGB1 Protein, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.